The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma ; volume:13 ; number:1 ; day:10 ; month:11 ; year:2022 ; pages:1-17 ; date:12.2022
Nature Communications ; 13, Heft 1 (10.11.2022), 1-17, 12.2022
- Creator
-
Vdovin, Alexander
Jelinek, Tomas
Zihala, David
Sevcikova, Tereza
Durech, Michal
Sahinbegovic, Hana
Snaurova, Renata
Radhakrishnan, Dhwani
Turi, Marcello
Chyra, Zuzana
Popkova, Tereza
Venglar, Ondrej
Hrdinka, Matous
Hajek, Roman
Simicek, Michal
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-022-34654-2
- URN
-
urn:nbn:de:101:1-2023012422550339203746
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vdovin, Alexander
- Jelinek, Tomas
- Zihala, David
- Sevcikova, Tereza
- Durech, Michal
- Sahinbegovic, Hana
- Snaurova, Renata
- Radhakrishnan, Dhwani
- Turi, Marcello
- Chyra, Zuzana
- Popkova, Tereza
- Venglar, Ondrej
- Hrdinka, Matous
- Hajek, Roman
- Simicek, Michal
- SpringerLink (Online service)
Other Objects (12)
The role of the deubiquitinase USP24 in multiple myeloma
USP13 regulates HMGB1 stability and secretion through its deubiquitinase activity
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models
Proteasome inhibition: the dawn of novel therapies in multiple myeloma
Phosphorylation-dependent deubiquitinase OTUD3 regulates YY1 stability and promotes colorectal cancer progression
Ubiquitin specific peptidase 3: an emerging deubiquitinase that regulates physiology and diseases
The deubiquitinase USP32 regulates non-proteolytic ubiquitination in the endosomal-lysosomal system
Cardiac events during treatment with proteasome inhibitor therapy for multiple myeloma
Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma
The role of the deubiquitinase USP24 in multiple myeloma
USP13 regulates HMGB1 stability and secretion through its deubiquitinase activity
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models
Proteasome inhibition: the dawn of novel therapies in multiple myeloma
Phosphorylation-dependent deubiquitinase OTUD3 regulates YY1 stability and promotes colorectal cancer progression
Ubiquitin specific peptidase 3: an emerging deubiquitinase that regulates physiology and diseases
The deubiquitinase USP32 regulates non-proteolytic ubiquitination in the endosomal-lysosomal system
Cardiac events during treatment with proteasome inhibitor therapy for multiple myeloma
Tetrahydrobiopterin induces proteasome inhibitor resistance and tumor progression in multiple myeloma
The role of the deubiquitinase USP24 in multiple myeloma
USP13 regulates HMGB1 stability and secretion through its deubiquitinase activity
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models
Proteasome inhibition: the dawn of novel therapies in multiple myeloma
Phosphorylation-dependent deubiquitinase OTUD3 regulates YY1 stability and promotes colorectal cancer progression
Ubiquitin specific peptidase 3: an emerging deubiquitinase that regulates physiology and diseases
The deubiquitinase USP32 regulates non-proteolytic ubiquitination in the endosomal-lysosomal system
Cardiac events during treatment with proteasome inhibitor therapy for multiple myeloma